Will formal entry into the European Union enable the eight new Central European members to galvanize their biotech sectors? Clare Sansom reports.
References
Sansom, C. European biotechnology turns east. Nat. Biotechnol. 17, 437–439 (1999).
Dickson, D. et al. What next for science in Central Europe. Nature 372, 591–592 (1994).
European Commission Directorate-General for Research. Towards a European Research Area Science, Technology, Innovation (European Commission, Brussels, Belgium, 2003).
European Commission. Eurobarometer 2003. 4. Public Opinion in the Candidate Countries (European Commission, Brussels, Belgium, 2004).
Petition for a new and ambitious European science policy (European Life Scientist Organization, posted February 24, 2004). http://ultr23.vub.ac.be/petition/
Vanecek, J. Pharmacy and biotechnology in the Czech Republic. http://www.tc.cz/dokums/biotechnology_in_czech9uk-revision_1100_1.pdf
Ernst and Young. Beyond Borders. The Global Biotechnology Report, 2002 (Ernst and Young, New York, June 2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sansom, C. EU expansion: enlarged horizons or false dawn?. Nat Biotechnol 22, 501–504 (2004). https://doi.org/10.1038/nbt0504-501
Issue Date:
DOI: https://doi.org/10.1038/nbt0504-501
- Springer Nature America, Inc.
This article is cited by
-
More than the sum of their parts?
EMBO reports (2006)